Its new chief executive, Anthony Fernando, who has been at the job for four months and with the company since 2015, is slated to present at the 38th Annual J.P. Morgan Healthcare Conference at The Westin St. Francis Hotel in San Francisco, California.
Read More
Investors have so far not reacted well to a reverse stock split that medical device firm TransEnterix executed on Wednesday evening as part of a stragegy to revive its shares and financials.
Read More
Robotic surgery company TransEnterix has put a new chief executive officer in place as the company – its stock trading around 30 cents, one 10th its value a year ago, continues to mull its strategic options such as a possible sale.
Read More
Medical device firm TransEnterix says it will seek shareholder approval for a reverse stock split that, if successful, would reduce the number of company shares and drive up their value.
Read More
Robotic surgery firm TransEnterix will explore options for the company’s future – including a possible sale – and also will go through a corporate restructuring, the company says.
Read More
A host of Triangle and N.C. tech/life science firms reported financial results this week. Here’s a wrapup:
Read More
The global marketplace for a robotic surgical system developed by Triangle-based TransEnterix continues to expand.
Read More
The chief executive officer and chief financial officer of surgical robotics company TransEnterix landed significant increases in total compensation in 2018, according to a filing Friday with the Securities and Exchange Commission.
Read More
Shares of TransEnterix Inc., a Morrisville-based surgical robot company, dropped sharply over the past two days due to a worse-than-expected net loss in the fourth quarter. But its CEO remains optimistic.
Read More
